Insider trade

Officer sold ~$313K of GILD shares in the open market

Traded Nov 17, 2025 · Filed Nov 18, 2025

~$313K
Reported value · 2,476 sh @ $126.2575: 107K
Holds after · shares reported: +18.9%
stock since the trade · S&P 500 +14.8%, $124.09 → $147.50 on Oct 1

Why it stands out

Gilead Sciences's Chief Commercial Officer sold $313K of Gilead Sciences shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Nov 17, 2025
Reporting period: Not applicable
Filed with the SEC: Nov 18, 2025

Officer$100K–$500KPre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$312,614

Shares × reported transaction price

Timing vs results

18 days after results of Oct 30, 2025, 85 days before results of Feb 10, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $124.09 on Nov 17, 2025, within 1% of its 52-week high, after a 9% rise over the previous 30 trading days

52-week range $87.75 (Nov 19, 2024) to $125.20 (Nov 13, 2025), 97% of the way up, from 250 adjusted closes. 30 trading days earlier: $113.58 on Oct 6, 2025. Describes the past only, not a forecast

Layoff notice nearby

A WARN layoff notice covering 17 workers was filed in California on November 12, 2025.

From the official state WARN list, 5 days before the trade. Shown for timing only; the two filings are separate

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	-0.4%	+2.6%	-3.0%
30 days	-3.0%	+2.7%	-5.7%
90 days	+21.2%	+3.0%	+18.2%
180 days	+1.3%	+11.5%	-10.2%

Past results only. Not a forecast.

Source receipt

Record ID: 0001782135-25-000013
Filed / recorded: Nov 18, 2025, 11:51 PM UTC
Added to OQRO: Oct 2, 2026, 12:27 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: GILEAD SCIENCES, INC.
Issuer CIK: 882095
Ticker: GILD
Reporting person: Johanna Mercier
Relationship: Officer
Officer title: Chief Commercial Officer
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Nov 17, 2025
Transaction code: S
Shares / units: 2,476
Price per share: $126.2575
Acquired / disposed: Disposed (D)
Shares owned after: 107,193
Ownership form: Direct
Amendment: No

Footnotes from the filing

The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
Sales prices for the transactions reported here range from $126.23 to $126.39. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.